Q4 2024 Earnings Conference Call March 4, 2025 8:00 AM ETCompany ParticipantsJerrit Peter - Head of IRDavid Allemann - ...

Bayer AG is the name of the holding company that looks after all Bayer’s separate operational and strategic managements. The group’s core businesses have been transformed into limited ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Roche Holding AG operates through two segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment focuses on oncology, immunology, ophthalmology, infectious diseases and neuroscience ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in ...

Shares of OTCMKTS RHHBY opened at $42.00 on Friday. Roche has a fifty-two week low of $29.20 and a fifty-two week high of $43.96. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0 ...

Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the ...

Cloud-based Elite platform to roll out to Roche's laboratory network across 50+ countries and a target 1,000 installations over five years. BASEL, Switzerland, March 18, 2025 /PRNewswire/ ...

Roche secures Zealand obesity drug candidate for up to $5.3 billion Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as ...

Roche Holding AG hired a senior executive from rival Novo Nordisk A/S as the Swiss drugmaker prepares to enter the hyper-competitive market for obesity drugs. Morten Lammert will join Roche as its ...